INTEGRATED FILING — Other than Banks



General information about company

Scrip code 539660
NSE Symbol BESTAGRO
MSEI Symbol NOTLISTED
ISIN INE052T01013
Name of Company BEST AGROLIFE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 24-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 20-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment AGROCHEMICALS
Start date and time of board meeting 24-May-2025   14:00:00
End date and time of board meeting 24-May-2025   15:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2022-01-25
Indicate Company website link for updated RPT policy of the Company https://www.bestagrolife.com/investors
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NO DEFAULT DURING THE SAID QUARTER


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 1557400000 11436500000
Other income 11600000 60300000
Total Income 1569000000 11496800000
2 Expenses
(a) Cost of materials consumed 0 204100000
(b) Purchases of stock-in-trade 1063000000 7643800000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 204100000 868200000
(d) Employee benefit expense 120400000 603100000
(e) Finance costs 83300000 409600000
(f) Depreciation and amortisation expense
(g) Other Expenses
1 Other Expenses 207000000 1088700000
Total other expenses 207000000 1088700000
Total expenses 1695800000 10888100000
3 Profit before exceptional and extraordinary items and tax
4 Exceptional items
5 Profit before extraordinary items and tax
6 Extraordinary items
7 Profit before tax -126800000 608700000
8 Tax Expense
Current tax -23200000 177200000
Deferred tax -9100000 -13200000
Total tax expenses -32300000 164000000
9 Net Profit Loss for the period from continuing operations
10 Profit (loss) from discontinuing operations before tax
11 Tax expense of discontinuing operations
12 Net profit (loss) from discontinuing operation after tax
13 Profit (loss) for period before minority interest
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period
17 Details of equity share capital
Paid-up equity share capital 236400000 236400000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 3722500000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -4 18.81
Diluted earnings (loss) per share from continuing and discontinued operations -4 18.81
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 409600000
Adjustments for depreciation and amortisation expense 70600000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 6000000
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss)
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 868200000
Adjustments for decrease (increase) in trade receivables
Adjustments for decrease (increase) in other current assets 1064000000
Adjustments for increase (decrease) in trade payables
Adjustments for increase (decrease) in other current liabilities -58700000
Adjustments for provisions
Total adjustments for working capital
Total adjustments for reconcile profit (loss) 771000000
Net cash flows from (used in) operations 1379700000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 69000000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) operating activities 1310700000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 50900000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 36100000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 506100000
Cash receipts from repayment of advances and loans made to other parties 314900000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 65300000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 68700000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) investing activities -144100000
Cash flows from used in financing activities
Proceeds from issuing shares
Proceeds from issuing other equity instruments 375000000
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -549100000
Repayments of borrowings 399200000
Dividends paid 71000000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash -404700000
Net cash flows from (used in) financing activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) financing activities -1073500000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 93100000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 93100000
Cash and cash equivalents cash flow statement at beginning of period 152600000
Cash and cash equivalents cash flow statement at end of period 245700000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital
Reserves and surplus
Money received against share warrants
Total shareholders' funds
2 Share application money pending allotment
3 Deferred government grants
4 Minority interest
5 Non-current liabilities
Long-term borrowings
Deferred tax liabilities (net) 0
Foreign currency monetary item translation difference liability account
Other long-term liabilities
Long-term provisions
Total non-current liabilities 93400000
6 Current liabilities
Short-term borrowings
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other current liabilities 385400000
Short-term provisions
Total current liabilities 5217600000
Total equity and liabilities 9748900000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 195800000
Producing properties
Intangible assets
Preproducing properties
Property, Plant and Equipment capital work-in-progress
Intangible assets under development or work-in-progress
Total Property, Plant and Equipment and Intangible assets
ii Non-current investments 1215000000
v Deferred tax assets (net) 41200000
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances
viii Other non-current assets 145600000
Total non-current assets 1771800000
Current assets
Current investments 0
Inventories 2855100000
Trade receivables
Cash and cash equivalents 245700000
Bank balance other than cash and cash equivalents 461500000
Short-term loans and advances
Other current assets
Total current assets 7977100000
Total assets 9748900000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Walker Chandiok & Co LLP Yes 31-May-2025


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth


Signatories details

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 27-Dec-2024
Amount Raised 1500000000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CRISIL RATINGS LIMITED
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review None
Comments of the auditors, if any None
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital Expenditure The Board in its meeting held on December 27, 2024 approved Rs.50 crore towards capital expenditure instead of 70 crores 700000000 500000000 0 0
2 Working capital The Board in its meeting held on December 27, 2024 approved Rs. 120 crore towards capital expenditure instead of 90 crores 1200000000 900000000 367700000 0 Total unutilized amount Rs 0.73 Crore
3 General Corporate Purpose No change 100000000 100000000 0 0


Signatory Details
Name of signatory Vikas sohanlal Jain
Designation of person Chief Financial Officer
Place New Delhi
Date 24-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 BEST AGROLIFE LIMITED VIMAL KUMAR Promoter & Managing Director Remuneration 24000000 No 12000000 0 0
2 BEST AGROLIFE LIMITED VIMAL KUMAR Promoter & Managing Director Any other transaction Rent Paid No 0 0 0
3 BEST AGROLIFE LIMITED VIMAL KUMAR Promoter & Managing Director Any other transaction Reimbursement No 0 0 0
4 BEST AGROLIFE LIMITED VANDANA ALAWADHI Promoter & Relative of KMP Any other transaction Rent Paid 10000000 No 4500000 0 0
5 BEST AGROLIFE LIMITED SHUVENDU KUMAR SATPATHY Non-Executive Director Remuneration 2000000 No 0 0 0
6 BEST AGROLIFE LIMITED SHUVENDU KUMAR SATPATHY Non-Executive Director Any other transaction Reimbursement No 0 0 0
7 BEST AGROLIFE LIMITED ISHA LUTHRA Whole-Time Director Remuneration 2500000 No 0 0 0
8 BEST AGROLIFE LIMITED BRAJ KISHORE PRASAD Independent Director Any other transaction Sitting fees No 0 0 0
9 BEST AGROLIFE LIMITED CHETNA Independent Director Any other transaction Sitting fees No 0 0 0
10 BEST AGROLIFE LIMITED ASTHA WAHI Company Secretary Remuneration 2000000 No 0 0 0
11 BEST AGROLIFE LIMITED PANKAL LUTHRA Other Related Party Remuneration 2000000 No 0 0 0
12 BEST AGROLIFE LIMITED PANKAL LUTHRA Other Related Party Loan No 0 0 0
13 BEST AGROLIFE LIMITED BEST CROP SCIENCE PRIVATE LIMITED Subsidiary Loan 2500000000 No 0 0 0
14 BEST AGROLIFE LIMITED BEST CROP SCIENCE PRIVATE LIMITED Subsidiary Any other transaction Loan Payment received No 0 0 0
15 BEST AGROLIFE LIMITED BEST CROP SCIENCE PRIVATE LIMITED Subsidiary Sale of goods or services 10000000000 No 369000000 0 0
16 BEST AGROLIFE LIMITED BEST CROP SCIENCE PRIVATE LIMITED Subsidiary Purchase of goods or services 10000000000 No 89400000 0 0
17 BEST AGROLIFE LIMITED BEST CROP SCIENCE PRIVATE LIMITED Subsidiary Interest received No 0 0 0
18 BEST AGROLIFE LIMITED SEEDLINGS INDIA PRIVATE LIMITED Subsidiary Sale of goods or services 5000000000 No 80800000 0 0
19 BEST AGROLIFE LIMITED SEEDLINGS INDIA PRIVATE LIMITED Subsidiary Purchase of goods or services 5000000000 No 332800000 0 0
20 BEST AGROLIFE LIMITED SEEDLINGS INDIA PRIVATE LIMITED Subsidiary Interest received No 5800000 0 0
21 BEST AGROLIFE LIMITED SEEDLINGS INDIA PRIVATE LIMITED Subsidiary Loan 1000000000 No 0 270500000 0
22 BEST AGROLIFE LIMITED SUDARSHAN FARM CHEMICALS INDIA PRIVATE LIMITED Subsidiary Interest received 0 No 4500000 0 0
23 BEST AGROLIFE LIMITED YATIN WAHI & ASSOCIATES Other Related Party Any other transaction Professional fees 200000 No 100000 0 0
24 BEST AGROLIFE LIMITED KASHMIR CHEMICALS Subsidiary Sale of goods or services 500000000 No 15900000 0 0
25 BEST AGROLIFE LIMITED KASHMIR CHEMICALS Subsidiary Purchase of goods or services 500000000 No 130600000 0 0
26 BEST AGROLIFE LIMITED SURYADEVARA BALA VENKATA RAMA PRASAD Whole-Time Director Remuneration 20000000 No 0 0 0
27 BEST AGROLIFE LIMITED SURYADEVARA BALA VENKATA RAMA PRASAD Whole-Time Director Any other transaction Reimbursement No 0 0 0
28 BEST AGROLIFE LIMITED VIKAS SOHANLAL JAIN Chief Financial Officer Remuneration 15000000 No 0 0 0
29 BEST AGROLIFE LIMITED SUDARSHAN FARM CHEMICALS INDIA PRIVATE LIMITED Subsidiary Investment 95000000 No 0 95000000 95000000
30 BEST AGROLIFE LIMITED SUDARSHAN FARM CHEMICALS INDIA PRIVATE LIMITED Subsidiary Loan 1500000000 No 633600000 26800000 0
31 BEST AGROLIFE LIMITED KASHMIR CHEMICALS Subsidiary Investment No 0 103100000 103100000
32 BEST AGROLIFE LIMITED BEST CROP SCIENCE PRIVATE LIMITED Subsidiary Any other transaction Reimbursement No 12800000 0 0
33 BEST AGROLIFE LIMITED SEEDLINGS INDIA PRIVATE LIMITED Subsidiary Any other transaction Reimbursement No 12800000 0 0
34 BEST AGROLIFE LIMITED SEEDLINGS INDIA PRIVATE LIMITED Subsidiary Any other transaction Loan Payment received No 277800000 0 0
35 BEST AGROLIFE LIMITED PAVAS CHEMICALS PRIVATE LIMITED Other Related Party Any other transaction Rent Paid 50000000 No 500000 0 0
36 BEST AGROLIFE LIMITED SUDARSHAN FARM CHEMICALS INDIA PRIVATE LIMITED Subsidiary Any other transaction Loan Payment received No 660400000 0 0
Total value of transaction during the reporting period 2643300000





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt